More about

Fred Hutchinson

News
January 07, 2020
2 min read
Save

Fred Hutchinson Cancer Research Center names new president, director

Fred Hutchinson Cancer Research Center names new president, director

Fred Hutchinson Cancer Research Center has named Thomas J. Lynch Jr., MD, as its president and director.

News
December 20, 2019
5 min read
Save

Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high

Despite lower price of generic imatinib, overall costs for chronic myeloid leukemia remain high

ORLANDO — The price of generic imatinib has decreased substantially in the United States over the past 2 years, according to a speaker at ASH Annual Meeting and Exposition.

News
December 10, 2019
12 min read
Save

Harnessing the gut to improve cancer outcomes

Harnessing the gut to improve cancer outcomes

The gut microbiome — made up of more than a trillion microbes, archaea, viruses, phages, yeast, fungi and bacteria in the intestine — has long been linked to a variety of issues across medical disciplines, from mental health to digestion, allergies and immune function.

News
November 13, 2019
3 min read
Save

Melanoma rates decline among US adolescents, young adults

Melanoma rates decline among US adolescents, young adults

Incidence of invasive melanoma decreased among adolescents and young adults in the United States between 2006 and 2015, according to results of a population-based study published in JAMA Dermatology.

News
November 08, 2019
2 min read
Save

Off-the-shelf natural killer cells safe, clinically active for advanced Merkel cell carcinoma

Off-the-shelf natural killer cells safe, clinically active for advanced Merkel cell carcinoma

NATIONAL HARBOR, Md. — Allogeneic activated natural killer cell therapy resulted in some antitumor activity with no serious side effects in patients with metastatic Merkel cell carcinoma, according to the results of a phase 2 study presented at the SITC Annual Meeting.

News
October 30, 2019
5 min read
Save

Hematologists, oncologists elected to National Academy of Medicine

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

News
October 22, 2019
4 min read
Save

NCI-sponsored clinical trials cost-effective, ‘practice influential’

NCI-sponsored clinical trials cost-effective, ‘practice influential’

A study by the NCI-sponsored SWOG Cancer Research Network showed nearly half of the network’s phase 3 clinical trials influenced clinical care guidelines or new drug approvals.

News
October 10, 2019
1 min read
Save

T-cell Responses to Concurrent HIV and Herpesvirus Infections

An observational, prospective cohort study to discover new information about how HIV and herpes viruses interact with the immune system, with a goal of learning more about how T cells in the immune system respond to and fight off long-term (chronic) viruses, in order to improve medical care in the future.

News
October 10, 2019
1 min read
Save

TCR-engineered T Cells in Solid Tumors (ACTengine)

Phase 1 study evaluating the safety and tolerability of genetically modified autologous T cells expressing a T-cell receptor recognizing a cancer/germline antigen in patients with relapsed and/or refractory solid tumors (ACTengine IMA203-101)

News
October 10, 2019
1 min read
Save

NY-ESO-1 TCR Engineered T Cell and HSC After Melphalan Conditioning Regimen in Treating Participants with Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Phase 1, open-label study evaluating the safety and efficacy of adoptive transfer of autologous NY-ESO-1 CD8-TCR engineered T cells and NY-ESO-1 CD4-TCR engineered hematopoietic stem cells after a myeloablative conditioning regimen, with administration of IL-2 in patients with relapsed or treatment-refractory ovarian, fallopian tube or primary peritoneal cancer.

View more